Pelthos CEO to Present at Oppenheimer Healthcare Conference Feb. 26
Pelthos Therapeutics CEO Scott Plesha will present at the Oppenheimer Healthcare Life Sciences Conference on February 26, 2026, at 10:00 a.m. Eastern with a webcast replay available for 90 days. Management will host one-on-one investor meetings, highlighting its commercial cutaneous infectious disease portfolio led by ZELSUVMI topical gel.
1. Conference Presentation
Scott Plesha, Pelthos Therapeutics CEO, will speak at the Oppenheimer Healthcare Life Sciences Conference on February 26, 2026, at 10:00 a.m. Eastern Time.
2. Webcast and Replay
The live presentation will be webcast with a replay accessible for 90 days in the Investors section of Pelthos’ website.
3. Investor Meetings
The management team has scheduled one-on-one meetings with investors and attendees during the conference; interested parties should contact their Oppenheimer representative to arrange sessions.
4. Product Portfolio
Pelthos is a commercial-stage biopharmaceutical company with a portfolio of cutaneous infectious disease products, led by ZELSUVMI topical gel for molluscum contagiosum and including Xepi cream and Xeglyze for head lice.